S.L. Tunis
Eli Lilly and Company
Indianapolis
USA
Name/email consistency: high
- Designing naturalistic prospective studies of economic and effectiveness outcomes associated with novel antipsychotic therapies. Tunis, S.L., Johnstone, B.M., Kinon, B.J., Barber, B.L., Browne, R.A. Value. Health (2000)
- Reliability, validity, and application of the medical outcomes study 36-item short-form health survey (SF-36) in schizophrenic patients treated with olanzapine versus haloperidol. Tunis, S.L., Croghan, T.W., Heilman, D.K., Johnstone, B.M., Obenchain, R.L. Med. Care (1999)
- Changes in perceived health and functioning as a cost-effectiveness measure for olanzapine versus haloperidol treatment of schizophrenia. Tunis, S.L., Johnstone, B.M., Gibson, P.J., Loosbrock, D.L., Dulisse, B.K. J. Clin. Psychiatry (1999)